Skip to content

Select language:

1800 620 420

Blood cancer information
How we can help
Get involved

Donate Menu Search

Home
Blood cancer information
How we can help
Research
Advocacy & policy
Get involved
Make a donation
About us
News
Contact us

Search

Home prognosisGlossary

prognosis

An estimate of the likely course and outcome of a disease.

< Back to glossary index

Share on

Print

Blood cancer A – Z

Acute lymphoblastic leukaemia (ALL)
Acute myeloid leukemia (AML)
Acute promyelocytic leukaemia (APML)
Adult T-cell lymphoma (ATLL)
Anaplastic large cell lymphoma (ALCL)
Amyloidosis
Aplastic anaemia (AA)
Biphenotypic leukaemia
Burkitt’s lymphoma
Chronic lymphocytic leukaemia (CLL)
Chronic myeloid leukaemia (CML)
CNS lymphoma
Diffuse large B-cell lymphoma (DLBCL)
Double hit lymphoma (DHL)
Essential Thrombocythaemia (ET)
Follicular lymphoma (FL)
Hairy cell leukaemia (HCL)
Hodgkin lymphoma (HL)
Leukaemia / Leukemia
Lymphoblastic lymphoma (LL)
Lymphoma
MALT lymphoma
Mantle cell lymphoma (MCL)
Marginal zone lymphoma (MZL)
Monoclonal gammopathy of unknown significance (MGUS)
Myelodysplastic syndromes (MDS)
Myelofibrosis (MF)
Myeloma
Myeloproliferative neoplasms (MPN)
Non-Hodgkin lymphoma (NHL)
Peripheral T-cell lymphoma (PTCL)
Polycythaemia (Rubra) vera (PRV)
Skin lymphomas
Small lymphocytic lymphoma (SLL)
Solitary plasmacytoma
Waldenstrom’s macroglobulinaemia (WM)

Curing and conquering
blood cancer

The Leukaemia Foundation acknowledges the traditional owners of country throughout Australia and recognises their continuing connection to land, sea and community. We pay our respects to their Elders past, present and emerging.

Sign up for news

Need to talk?

Speak with our Blood Cancer Support Coordinators via 1800 620 420

Join our Facebook groups

Express concerns, ask questions and share information on living with blood cancer.

Join our networks

Connect with us

© 2023 Leukaemia Foundation

Privacy
Disclaimer
Site map
Contact us